Profile data is unavailable for this security.
About the company
Bionano Genomics, Inc. is a genomics company. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
- Revenue in USD (TTM)37.47m
- Net income in USD-226.79m
- Incorporated2003
- Employees344.00
- LocationBionano Genomics Inc9640 TOWNE CENTRE DRIVE9640 TOWNE CENTRE DRIVESAN DIEGO 92121United StatesUSA
- Phone+1 (858) 888-7600
- Fax+1 (858) 888-7601
- Websitehttps://bionano.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clearsign Technologies Corp | 2.40m | -5.19m | 38.95m | 15.00 | -- | 5.83 | -- | 16.21 | -0.1350 | -0.1350 | 0.0624 | 0.1342 | 0.2592 | -- | 8.37 | 160,200.00 | -56.02 | -61.67 | -68.60 | -69.43 | 34.00 | 5.94 | -216.15 | -1,010.99 | -- | -- | 0.00 | -- | 542.51 | 35.30 | 9.80 | -- | -16.81 | -- |
| Fossil Group Inc | 1.34bn | -140.12m | 69.34m | 6.10k | -- | 0.3002 | -- | 0.0517 | -2.67 | -2.67 | 25.59 | 4.36 | 1.36 | 2.46 | 8.85 | 220,038.00 | -14.14 | -4.59 | -20.23 | -7.24 | 48.60 | 49.48 | -10.41 | -3.63 | 1.40 | -3.94 | 0.473 | -- | -16.05 | -11.09 | -255.75 | -- | -13.84 | -- |
| Midwest Energy Emissions Corp | 17.94m | 5.90m | 76.11m | 9.00 | 15.84 | -- | 12.43 | 4.24 | 0.051 | 0.051 | 0.1841 | -0.0083 | 0.9748 | 13.63 | 7.16 | 1,993,376.00 | 32.08 | -21.65 | 37.61 | -47.81 | 32.15 | 32.80 | 32.91 | -15.57 | 10.70 | -6.19 | 1.08 | -- | -17.02 | 7.85 | 473.32 | -- | -- | -- |
| BioNano Genomics Inc | 37.47m | -226.79m | 76.22m | 344.00 | -- | 0.7925 | -- | 2.03 | -6.15 | -6.15 | 0.942 | 1.44 | 0.1665 | 1.03 | 4.97 | 108,924.40 | -100.76 | -56.82 | -128.31 | -67.83 | 27.54 | 25.38 | -605.26 | -505.76 | 1.13 | -83.42 | 0.0444 | -- | 29.90 | 24.65 | -75.34 | -- | 38.51 | -- |
| Luna Innovations Inc | 116.61m | -1.12m | 102.22m | 337.00 | -- | 1.08 | 23.09 | 0.8765 | -0.0339 | -0.0637 | 3.45 | 2.79 | 0.7515 | 1.26 | 2.84 | 346,035.60 | -0.7231 | 0.8556 | -0.9292 | 1.09 | 59.00 | 56.43 | -0.9622 | 1.23 | 1.62 | 0.1366 | 0.2521 | 0.00 | 25.12 | 27.05 | -111.20 | -- | 16.38 | -- |
| Babcock & Wilcox Enterprises Inc | 965.65m | -96.86m | 111.94m | 2.20k | -- | -- | -- | 0.1159 | -1.08 | -2.42 | 10.82 | -2.49 | 1.09 | 6.71 | 5.28 | 438,932.70 | -9.27 | -5.50 | -16.03 | -11.87 | 22.85 | 22.90 | -8.47 | -5.30 | 1.11 | 0.530 | 1.90 | -- | 17.86 | -1.22 | -201.13 | -- | 12.36 | -- |
| Virtra Inc | 38.04m | 8.40m | 112.32m | 112.00 | 13.21 | 2.63 | 12.04 | 2.95 | 0.7653 | 0.7653 | 3.47 | 3.84 | 0.6163 | 1.03 | 2.78 | 339,672.80 | 13.61 | 7.69 | 17.16 | 9.70 | 70.09 | 59.06 | 22.09 | 11.12 | 2.32 | -- | 0.1587 | -- | 34.42 | 16.04 | 329.62 | 59.34 | 30.96 | -- |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2024 | 1.88m | 3.45% |
| GSA Capital Partners LLPas of 31 Mar 2024 | 549.79k | 1.01% |
| GMT Capital Corp.as of 31 Dec 2023 | 530.25k | 0.97% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 514.23k | 0.94% |
| Two Sigma Investments LPas of 31 Dec 2023 | 407.41k | 0.75% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 385.12k | 0.70% |
| Geode Capital Management LLCas of 31 Dec 2023 | 376.80k | 0.69% |
| Citadel Securities LLCas of 31 Dec 2023 | 202.22k | 0.37% |
| Millennium Management LLCas of 31 Dec 2023 | 196.43k | 0.36% |
| D. E. Shaw & Co. LPas of 31 Dec 2023 | 171.76k | 0.31% |
